ANVISA registration 82568320016Valid until Mar 02, 2036CORONAVIRUS
ANVISA Registration Number: 82568320016GLOBALX PHARMA LTDA.HANGZHOU ALLTEST BIOTECH CO. LTDRisk Class III
Device names
- Commercial name
- Teste Rápido de Antígeno para SARS-CoV-2 GlobalX AT
- Risk class
- Class III
Registration details
- Registration Number
- 82568320016
- Process Number
- 25351215186202515
- CNPJ
- 41775241000190
Company information
- Registration Holder
- GLOBALX PHARMA LTDA.
- Manufacturer
- HANGZHOU ALLTEST BIOTECH CO. LTD
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- Mar 02, 2026
- Validity
- 02/03/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for CORONAVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 82568320016 and manufactured by HANGZHOU ALLTEST BIOTECH CO. LTD. The registration is held by GLOBALX PHARMA LTDA. with validity until Mar 02, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.